These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26624805)

  • 1. Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines.
    Zhang L; Zeng Z; Hu C; Bellis SL; Yang W; Su Y; Zhang X; Wu Y
    Biomaterials; 2016 Jan; 77():307-19. PubMed ID: 26624805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of cationic-PLGA microspheres loaded with DNA vaccine encoding the sip gene of Streptococcus agalactiae in tilapia.
    Ma YP; Ke H; Liang ZL; Ma JY; Hao L; Liu ZX
    Fish Shellfish Immunol; 2017 Jul; 66():345-353. PubMed ID: 28476676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip.
    Yao YY; Chen DD; Cui ZW; Zhang XY; Zhou YY; Guo X; Li AH; Zhang YA
    Fish Shellfish Immunol; 2019 Mar; 86():999-1008. PubMed ID: 30590166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant lactococcal-based oral vaccine for protection against Streptococcus agalactiae infections in tilapia (Oreochromis niloticus).
    Wong KY; Megat Mazhar Khair MH; Song AAL; Masarudin MJ; Loh JY; Chong CM; Beardall J; Teo MYM; In LLA
    Fish Shellfish Immunol; 2024 Jun; 149():109572. PubMed ID: 38636739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectivity of oral recombinant DNA vaccine against Streptococcus agalactiae in Nile tilapia.
    Zhu L; Yang Q; Huang L; Wang K; Wang X; Chen D; Geng Y; Huang X; Ouyang P; Lai W
    Dev Comp Immunol; 2017 Dec; 77():77-87. PubMed ID: 28757159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant truncated surface immunogenic protein (tSip) plus adjuvant FIA confers active protection against Group B streptococcus infection in tilapia.
    He Y; Wang KY; Xiao D; Chen DF; Huang L; Liu T; Wang J; Geng Y; Wang EL; Yang Q
    Vaccine; 2014 Dec; 32(51):7025-7032. PubMed ID: 25446833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and evaluation of an oral vaccine via nano-carrier for surface immunogenic protein (Sip) delivery against Streptococcus agalactiae infection.
    Zhu C; Zhang N; Jing D; Liu X; Zeng Z; Wang J; Xiao F; Zhang H; Chi H; Wan C; Lin P; Gong H; Wu Y
    Int J Biol Macromol; 2023 Apr; 235():123770. PubMed ID: 36822292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of an oral DNA vaccine encoding Sip of Streptococcus agalactiae from Nile tilapia Oreochromis niloticus delivered by live attenuated Salmonella typhimurium.
    Huang LY; Wang KY; Xiao D; Chen DF; Geng Y; Wang J; He Y; Wang EL; Huang JL; Xiao GY
    Fish Shellfish Immunol; 2014 May; 38(1):34-41. PubMed ID: 24631734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral vaccine based on a surface immunogenic protein mixed with alum promotes a decrease in Streptococcus agalactiae vaginal colonization in a mouse model.
    Diaz-Dinamarca DA; Soto DA; Leyton YY; Altamirano-Lagos MJ; Avendaño MJ; Kalergis AM; Vasquez AE
    Mol Immunol; 2018 Nov; 103():63-70. PubMed ID: 30205305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with whole-cell vaccine and bacterial protein extract protects tilapia against Streptococcus difficile meningoencephalitis.
    Eldar A; Shapiro O; Bejerano Y; Bercovier H
    Vaccine; 1995 Jun; 13(9):867-70. PubMed ID: 7483810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
    Nur-Nazifah M; Sabri MY; Siti-Zahrah A
    Fish Shellfish Immunol; 2014 Mar; 37(1):193-200. PubMed ID: 24486904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro.
    Li LP; Wang R; Liang WW; Huang T; Huang Y; Luo FG; Lei AY; Chen M; Gan X
    Fish Shellfish Immunol; 2015 Aug; 45(2):955-63. PubMed ID: 26087276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of mucoadhesive polymer in enhancing efficacy of direct immersion vaccination against Flavobacterium columnare infection in tilapia.
    Kitiyodom S; Kaewmalun S; Nittayasut N; Suktham K; Surassmo S; Namdee K; Rodkhum C; Pirarat N; Yata T
    Fish Shellfish Immunol; 2019 Mar; 86():635-640. PubMed ID: 30528659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoproteomic analysis of the antibody response obtained in Nile tilapia following vaccination with a Streptococcus iniae vaccine.
    LaFrentz BR; Shoemaker CA; Klesius PH
    Vet Microbiol; 2011 Sep; 152(3-4):346-52. PubMed ID: 21601381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening vaccine candidate strains against Streptococcus agalactiae of tilapia based on PFGE genotype.
    Chen M; Wang R; Li LP; Liang WW; Li J; Huang Y; Lei AY; Huang WY; Gan X
    Vaccine; 2012 Sep; 30(42):6088-92. PubMed ID: 22867719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced efficacy of immersion vaccination in tilapia against columnaris disease by chitosan-coated "pathogen-like" mucoadhesive nanovaccines.
    Kitiyodom S; Yata T; Yostawornkul J; Kaewmalun S; Nittayasut N; Suktham K; Surassmo S; Namdee K; Rodkhum C; Pirarat N
    Fish Shellfish Immunol; 2019 Dec; 95():213-219. PubMed ID: 31585248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a novel Streptococcus agalactiae ghost vaccine and examination of its immunogenicity against virulent challenge in tilapia.
    Wang Q; Wang X; Wang X; Feng R; Luo Q; Huang J
    Fish Shellfish Immunol; 2018 Oct; 81():49-56. PubMed ID: 29969706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
    Evans JJ; Klesius PH; Shoemaker CA
    Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Streptococcus agalactiae vaccines for tilapia.
    Liu G; Zhu J; Chen K; Gao T; Yao H; Liu Y; Zhang W; Lu C
    Dis Aquat Organ; 2016 Dec; 122(2):163-170. PubMed ID: 28000606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): Insight into vaccine development.
    Li W; Wang HQ; He RZ; Li YW; Su YL; Li AX
    Fish Shellfish Immunol; 2016 Aug; 55():737-46. PubMed ID: 27327442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.